Legal Representation
Attorney
Sarah Otte Graber
USPTO Deadlines
Next Deadline
1418 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-30)
Due Date
May 30, 2029
Grace Period Ends
November 30, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description |
|---|---|---|---|
| May 30, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| May 30, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Apr 28, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Apr 27, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 27, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Apr 26, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 26, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Apr 26, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Apr 6, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Apr 6, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Apr 6, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Apr 6, 2023 | IUAF | S | USE AMENDMENT FILED |
| Nov 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 3, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 3, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 3, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 3, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 1, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Feb 1, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Feb 1, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Feb 1, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Feb 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 29, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 28, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 28, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 28, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 28, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 28, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 28, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 28, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 28, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 26, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 16, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 15, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 18, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Signal generators for use with medical devices; connection cables for use with medical devices
First Use Anywhere:
Oct 4, 2015
First Use in Commerce:
Oct 4, 2015
Class 010
Medical apparatus and instruments for renal denervation, treating and reducing hypertension, and controlling blood pressure; Medical device systems consisting of medical devices for renal denervation, treating and reducing hypertension, and controlling blood pressure; ultra-sound-emitting catheters used to perform denervation in human beings; medical devices for treating hypertension; medical devices used to perform denervation; medical device systems consisting of devices used in a medical setting to perform intravascular denervation; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of medical devices, catheters, electrical generators, plastic cartridges for medical fluids, and connection cables, for medical devices for use in performing denervation of human beings; ultrasound renal denervation systems consisting of medical devices for renal denervation; energy emitting catheter-based systems consisting of medical devices and devices for medical procedures in the nature of neuromodulation and denervation of the autonomic nervous system for use in treating hypertension, and also consisting of catheters, electrical generators, plastic cartridges for medical fluids, and connection cables, for medical devices used in connection with the preceding systems and devices
First Use Anywhere:
Feb 12, 2016
First Use in Commerce:
Feb 12, 2016
Additional Information
Design Mark
The mark consists of a series of circles arranged in a circular pattern. The individual circles are gray, red, orange, blue or purple in color and vary in circumference depending upon color. The purple circles together form a circular ring in the center of the overall circular pattern, with the blue, orange, red and then gray circles all forming circular rings around each of the interior rings, with the gray circles being on the perimeter of the overall design.
Color Claim
The color(s) gray, red, orange, blue and purple is/are claimed as a feature of the mark.
Classification
International Classes
009
010